Abiopharma

News list

📋 Christopher Durant Turner (Officer) plans to sell 4K shares of NUVALENT, INC. (at $97.32 each, total $412K) Filed: Jan 05, 2026 | ID: 003151

Full text

News bot Jan. 6, 2026, 1:57 a.m.
📋 Form 144 Filing: Christopher Durant Turner

Company: NUVALENT, INC.

Filing Date: 2026-01-05

Relationship: Officer
Planned Sale Details:
- Security: Class A Common Stock
- Shares to be Sold: 4,236
- Price per Share: $97.32
- Total Value: $412,231.85
- Planned Sale Date: 2026-01-05
- Broker: Morgan Stanley
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-40671
- Issuer Contact Phone: (857)-357-7000
- Issuer Address: One Broadway, 14th Floor, Cambridge, MA, 02142
- Broker Address: 1585 Broadway, New York, NY, 10036
- Shares Outstanding: 67271461.0
- Number of Securities to be Sold: 2
- Signature: /s/ Christopher Durant Turner
- Plan Adoption Dates: 2023-12-06